Multicentric human papillomavirus-associated head and neck squamous cell carcinoma

被引:11
|
作者
Caley, Andrew [1 ]
Evans, Mererid [1 ]
Powell, Ned [2 ]
Paleri, Vinidh [3 ]
Tomkinson, Alun [4 ]
Urbano, Teresa Guerrero [5 ]
Jay, Amrita [6 ]
Robinson, Max [7 ]
Thavaraj, Selvam [8 ]
机构
[1] Velindre Canc Ctr, Dept Clin Oncol, Cardiff, S Glam, Wales
[2] Cardiff Univ, HPV Res Grp, Sch Med, Cardiff CF10 3AX, S Glam, Wales
[3] Newcastle Univ, Dept Otolaryngol Head & Neck Surg, Newcastle Upon Tyne Hosp NHS Trust, Northern Inst Canc Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
[4] Univ Wales Hosp, Dept Otolaryngol Head & Neck Surg, Cardiff CF4 4XW, S Glam, Wales
[5] Guys & St Thomas NHS Fdn Trust, London, England
[6] Univ Coll London Hosp, Dept Histopathol, London, England
[7] Newcastle Univ, Ctr Oral Hlth Res, Sch Dent Sci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
[8] Kings Coll London Dent Inst, London, England
基金
英国医学研究理事会;
关键词
second primary tumor; human papillomavirus; head and neck squamous cell carcinoma; multicentric; pharyngeal; RISK HUMAN-PAPILLOMAVIRUS; LOWER GENITAL-TRACT; OROPHARYNGEAL CANCER INCIDENCE; 2ND PRIMARY TUMORS; TONSILLAR CARCINOMA; UNITED-STATES; HPV; SURVIVAL; EPIDEMIC; TRENDS;
D O I
10.1002/hed.23584
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
BackgroundThe purpose of this study was to present the clinicopathological features of a series of patients with human papillomavirus (HPV)-associated head and neck second primary tumors. MethodsPatients with HPV-associated head and neck second primary tumors from 3 centers were identified. HPV infection was evaluated using p16 by immunohistochemistry (IHC), high-risk HPV DNA by in situ hybridization (ISH), and HPV genotyping by DNA polymerase chain reaction (PCR) enzyme immunoassay (EIA). ResultsEleven patients were identified: 5 with synchronous and 6 with metachronous HPV-positive second primary tumors, the latter demonstrating a mean time interval of 5 years. There were 13 second primary tumors: 11 oropharyngeal, 1 nasopharyngeal, and 1 floor of the mouth. Nine of 10 genotyped patients harbored HPV-16, and 1 patient had HPV-33 in 3 synchronous tumors. ConclusionHPV-associated second primary tumors may present as synchronous and/or metachronous lesions and can arise outside the oropharynx after prolonged intervals. Further work is necessary to identify patients at risk and to elucidate the mechanisms of HPV-associated head and neck second primary tumors. (c) 2014 Wiley Periodicals, Inc. Head Neck37: 202-208, 2015
引用
收藏
页码:202 / 208
页数:7
相关论文
共 50 条
  • [41] A Current Update on Human Papillomavirus-Associated Head and Neck Cancers
    Tumban, Ebenezer
    VIRUSES-BASEL, 2019, 11 (10):
  • [42] Update on Squamous Cell Carcinoma of the Nail Unit: An Human Papillomavirus-Associated Condition
    Bray, Eric R.
    Tosti, Antonella
    Morrison, Brian W.
    SKIN APPENDAGE DISORDERS, 2024, 10 (03) : 199 - 206
  • [43] Vaccine Strategies for Human Papillomavirus-Associated Head and Neck Cancers
    Zhou, Jade Z.
    Jou, Jessica
    Cohen, Ezra
    CANCERS, 2022, 14 (01)
  • [44] P16/INK4a Downregulation Is A Possible Trigger for Human Papillomavirus-associated Metachronous Head and Neck Squamous Cell Carcinoma
    Ota, Y.
    Sudo, T.
    Tsujino, K.
    Iwae, S.
    Ohbayashi, C.
    Soejima, T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S762 - S762
  • [45] Gene expression differences associated with human papillomavirus status in head and neck squamous cell carcinoma
    Slebos, RJC
    Yi, YJ
    Ely, K
    Carter, J
    Evjen, A
    Zhang, XQ
    Shyr, Y
    Murphy, BM
    Cmelak, AJ
    Burkey, BB
    Netterville, JL
    Levy, S
    Yarbrough, WG
    Chung, CH
    CLINICAL CANCER RESEARCH, 2006, 12 (03) : 701 - 709
  • [46] Characterization of gene methylation in human papillomavirus associated-head and neck squamous cell carcinoma
    Zhang, H. Z.
    Shan, C. G.
    Huang, A. P.
    Wang, J. M.
    GENETICS AND MOLECULAR RESEARCH, 2016, 15 (03)
  • [47] RNA-sequencing analysis implicates novel non-coding RNAs in human papillomavirus-associated head and neck squamous cell carcinoma
    Zou, Angela E.
    Krishnan, Aswini R.
    Xuan, Yinan
    Saad, Maarouf A.
    Korrapati, Avinaash
    Advani, Sunil J.
    Wang-Rodriguez, Jessica
    Ongkeko, Weg
    CANCER RESEARCH, 2016, 76
  • [48] Safety and Efficacy of MEDI0457 plus Durvalumab in Patients with Human Papillomavirus-Associated Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
    Aggarwal, Charu
    Saba, Nabil F.
    Algazi, Alain
    Sukari, Ammar
    Seiwert, Tanguy Y.
    Haigentz, Missak
    Porosnicu, Mercedes
    Bonomi, Marcelo
    Boyer, Jean
    Esser, Mark T.
    Cheng, Lily I.
    Agrawal, Sonia
    Jennings, Emily C.
    Durham, Nicholas M.
    Fraser, Karl
    Lissa, Delphine
    Gong, Maozhen
    Ceaicovscaia, Natalia
    Hernandez, Amaya Gasco
    Kumar, Rakesh
    CLINICAL CANCER RESEARCH, 2023, 29 (03) : 560 - 570
  • [49] The role of human papillomavirus in squamous carcinoma of the head and neck
    Li G.
    Sturgis E.M.
    Current Oncology Reports, 2006, 8 (2) : 130 - 139
  • [50] Retropharyngeal lymph node involvement in human papillomavirus-associated oropharyngeal squamous cell carcinoma
    Baxter, Michael
    Chan, Jason Y. K.
    Mydlarz, Wojciech K.
    Labruzzo, Salvatore V.
    Kiess, Ana
    Ha, Patrick K.
    Aygun, Nafi
    Agrawal, Nishant
    LARYNGOSCOPE, 2015, 125 (11): : 2503 - 2508